Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002812154 | SCV003208228 | pathogenic | Hereditary spastic paraplegia 48 | 2022-07-07 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. This sequence change creates a premature translational stop signal (p.Cys301*) in the AP5Z1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP5Z1 are known to be pathogenic (PMID: 20613862, 27606357). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. |